SG Americas Securities’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,971
Closed -$226K 2971
2023
Q1
$226K Buy
+7,971
New +$226K ﹤0.01% 2124
2022
Q4
Sell
-9,133
Closed -$241K 3033
2022
Q3
$241K Sell
9,133
-69
-0.7% -$1.82K ﹤0.01% 1923
2022
Q2
$409K Sell
9,202
-15,496
-63% -$689K ﹤0.01% 1944
2022
Q1
$1.22M Buy
24,698
+3,905
+19% +$193K 0.01% 1128
2021
Q4
$1.06M Sell
20,793
-32,095
-61% -$1.63M 0.01% 1465
2021
Q3
$2.95M Buy
52,888
+5,723
+12% +$319K 0.01% 848
2021
Q2
$2.02M Sell
47,165
-8,906
-16% -$381K 0.01% 1016
2021
Q1
$2.34M Sell
56,071
-4,032
-7% -$168K 0.01% 851
2020
Q4
$2.8M Buy
60,103
+37,162
+162% +$1.73M 0.01% 751
2020
Q3
$975K Sell
22,941
-33,488
-59% -$1.42M 0.01% 986
2020
Q2
$2.71M Buy
56,429
+20,193
+56% +$969K 0.02% 517
2020
Q1
$1.67M Buy
36,236
+15,047
+71% +$692K 0.02% 705
2019
Q4
$1.27M Buy
21,189
+12,639
+148% +$759K 0.01% 965
2019
Q3
$484K Buy
+8,550
New +$484K ﹤0.01% 1649
2019
Q2
Sell
-2,507
Closed -$127K 2924
2019
Q1
$127K Sell
2,507
-5,288
-68% -$268K ﹤0.01% 2529
2018
Q4
$314K Buy
+7,795
New +$314K ﹤0.01% 1825
2018
Q3
Sell
-7,046
Closed -$533K 2923
2018
Q2
$533K Sell
7,046
-3,989
-36% -$302K ﹤0.01% 1731
2018
Q1
$581K Buy
11,035
+3,650
+49% +$192K ﹤0.01% 1537
2017
Q4
$395K Buy
7,385
+2,874
+64% +$154K ﹤0.01% 1691
2017
Q3
$269K Buy
4,511
+1,706
+61% +$102K ﹤0.01% 2038
2017
Q2
$221K Sell
2,805
-217
-7% -$17.1K ﹤0.01% 2075
2017
Q1
$251K Sell
3,022
-3,738
-55% -$310K ﹤0.01% 2028
2016
Q4
$536K Buy
6,760
+4,385
+185% +$348K ﹤0.01% 1485
2016
Q3
$166K Buy
+2,375
New +$166K ﹤0.01% 2344
2015
Q4
Sell
-1,953
Closed -$145K 2513
2015
Q3
$145K Buy
+1,953
New +$145K ﹤0.01% 1643